Who is sponsoring NCT05677399?

NCT05677399 is sponsored by Istanbul Arel University.

What drugs are being tested in NCT05677399?

Interventions in NCT05677399: aquatic exercise and peloidotherapy.

What condition does NCT05677399 study?

NCT05677399 studies Knee Osteoarthritis.

Is NCT05677399 still recruiting?

NCT05677399 is currently completed. Last updated 10 January 2023.

Last reviewed 2023-01-10 · How we verify

NCT05677399

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.

Completed NA Last updated 10 January 2023

What this trial tests

NA trial testing aquatic exercise and peloidotherapy in Knee Osteoarthritis in 76 participants. Completed in 10 December 2016.

Timeline

9 September 2015

Primary endpoint
10 June 2016

10 December 2016

Quick facts

Lead sponsor	Istanbul Arel University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	76
Start date	9 September 2015
Primary completion	10 June 2016
Estimated completion	10 December 2016

Drugs / interventions tested

aquatic exercise and peloidotherapy

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Istanbul Arel University

Who can join

Adults 40 to 75, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim was to observe the short and medium term effects of peloidotherapy and aquatic exercise applications in patients with knee osteoarthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other Istanbul Arel University trials

Trials by the same sponsor.

NCT07518082 — Effect of Virtual Reality-Based Handwashing Education on Knowledge, Skills, and Attitudes in Preschool Children · NA · not yet recruiting
NCT07521917 — Child Abuse and Neglect Awareness Training in Nursing Students · NA · not yet recruiting
NCT07478406 — Relatıonshıp Between Pelvıc Floor and Venous Insuffıcıency · NA · enrolling by invitation
NCT07432464 — The Effect of Nomophobia Levels on Anxiety and Academic Self-Efficacy in Students With Text Neck · not yet recruiting
NCT07402187 — "Productivity Training and Job Stress Among Nurses" · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05677399 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Arel University
Last refreshed: 10 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05677399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing